Autumn Glory Partners LLC Has $275,000 Stake in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Autumn Glory Partners LLC reduced its stake in Sabra Healthcare REIT, Inc. by 67.3% in the 2nd quarter, owning 14,900 shares worth $275,000.
• Sabra Healthcare REIT reported a net margin of 24.87% and a revenue increase of 7.4% year-over-year, with earnings per share exceeding analysts' expectations.
• The company announced a quarterly dividend of $0.30 per share, equating to a 6.6% dividend yield, with a dividend payout ratio of 157.89%.

Autumn Glory Partners LLC reduced its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 67.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,900 shares of the real estate investment trust's stock after selling 30,700 shares during the period. Autumn Glory Partners LLC's holdings in Sabra Healthcare REIT were worth $275,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. QRG Capital Management Inc. grew its position in Sabra Healthcare REIT by 8.9% in the 2nd quarter. QRG Capital Management Inc. now owns 66,212 shares of the real estate investment trust's stock worth $1,221,000 after purchasing an additional 5,416 shares in the last quarter. Polaris Capital Management LLC purchased a new position in Sabra Healthcare REIT in the second quarter valued at about $1,870,000. Ameritas Advisory Services LLC purchased a new stake in shares of Sabra Healthcare REIT during the 2nd quarter valued at approximately $84,000. Hilltop National Bank purchased a new stake in shares of Sabra Healthcare REIT during the 2nd quarter valued at approximately $96,000. Finally, Venture Visionary Partners LLC lifted its stake in shares of Sabra Healthcare REIT by 2.4% during the 2nd quarter. Venture Visionary Partners LLC now owns 119,669 shares of the real estate investment trust's stock valued at $2,207,000 after buying an additional 2,848 shares in the last quarter. 99.40% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently commented on SBRA shares. Weiss Ratings restated a "buy (b)" rating on shares of Sabra Healthcare REIT in a research report on Saturday, September 27th. Cantor Fitzgerald initiated coverage on shares of Sabra Healthcare REIT in a report on Wednesday. They set a "neutral" rating and a $20.00 target price on the stock. Scotiabank raised their target price on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a research report on Monday, June 23rd. Wells Fargo & Company lifted their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a research report on Wednesday, August 27th. Finally, BMO Capital Markets lifted their target price on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a "market perform" rating in a report on Monday, August 25th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Sabra Healthcare REIT has an average rating of "Moderate Buy" and an average target price of $20.71.

Sabra Healthcare REIT Stock Down 0.7%

SBRA stock opened at $18.14 on Monday. The firm has a 50 day simple moving average of $18.77 and a 200-day simple moving average of $18.16. Sabra Healthcare REIT, Inc. has a twelve month low of $15.60 and a twelve month high of $20.03. The company has a market capitalization of $4.35 billion, a P/E ratio of 23.87, a PEG ratio of 1.45 and a beta of 0.85. The company has a current ratio of 4.80, a quick ratio of 4.80 and a debt-to-equity ratio of 0.91.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The business had revenue of $189.15 million for the quarter, compared to analysts' expectations of $185.64 million. During the same period in the previous year, the business earned $0.36 earnings per share. The company's revenue was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, equities research analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Friday, August 15th were issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 6.6%. The ex-dividend date was Friday, August 15th. Sabra Healthcare REIT's dividend payout ratio is presently 157.89%.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.